A new British Journal of Clinical Pharmacology study indicates that methylphenidate, a central nervous system stimulant approved to treat attention deficit hyperactivity disorder (ADHD) and narcolepsy, may be subject to misuse ...
Mar 7, 2018
0
4
For adolescents and adults with attention-deficit/hyperactivity disorder (ADHD), the use of ADHD medications is associated with fewer psychiatric and nonpsychiatric hospitalizations, according to a study published online ...
Mar 22, 2024
0
0
Physicians in Canada should consider refusing to prescribe cognitive enhancement medications—also used to treat attention deficit disorder (ADD)—to healthy patients, states an analysis article in CMAJ (Canadian Medical ...
Dec 17, 2012
0
0
Medication development efforts for cocaine dependence have yet to result in an FDA approved treatment. The powerful rewarding effects of cocaine, the profound disruptive impact of cocaine dependence on one's lifestyle, and ...
Nov 28, 2012
0
0
Amphetamine/dextroamphetamine and methylphenidate exposure in utero does not appear to increase the risk for childhood neurodevelopmental disorders, according to a study published online Jan. 24 in JAMA Psychiatry.
Feb 1, 2024
0
1
In a study of 1159 males who illicitly used amphetamines, half of participants said drug use had no impact on their sexual functions, while the other half reported impacts such as reduced erectile rigidity and sexual satisfaction, ...
Jul 6, 2015
0
7
Adults, including women of reproductive age, are increasingly being prescribed medications to treat Attention Deficit Hyperactivity Disorder (ADHD) but little evidence has been available about whether exposure to these drugs ...
Dec 13, 2017
0
4
Lisdexamfetamine dimesylate (trade name: Elvanse) has been approved in Germany since March 2013 as part of a comprehensive treatment programme for attention deficit/hyperactivity disorder (ADHD) in children aged 6 years and ...
Sep 3, 2013
0
0
